Translate images into discoveries, decisions,
and diagnoses

Aiforia equips pathologists and scientists in clinical, pre-clinical, and academic labs with powerful deep learning AI and cloud-based technology. Aiforia’s solutions strive to increase the speed, accuracy, and consistency of analyzing large and complex medical images, especially in pathology. Aiforia’s mission is to transform pathology image analysis with AI, enabling better care for each patient.

Find more about us

Clinical Solutions

For pathology labs looking to increase productivity and improve diagnostic accuracy, Aiforia Clinical Solutions offer AI-supported image-based diagnostics with intelligent visualization, automated screening, and reporting tools in one cloud-based platform. 

  • Aiforia® Breast Cancer Suite
  • Aiforia® Lung Cancer Suite
  • Aiforia® Prostate Cancer Suite
Ki67_20x_screen_right_cropped
+

Research Solutions

For pharma, biotech, CROs, and academic researchers, Aiforia Research Solutions offer cloud-based pathology image analysis applications that cater to all research areas. 

  • Aiforia® Create
 
MIT_screen_right
+

What Makes Aiforia Unique?

ic_our_ai-1_pink

Future-proof

Together with our customers, we continue to develop new groundbreaking AI models, with thousands of models already developed for research use. We’re committed to providing cutting-edge deep learning AI models designed to meet the evolving needs of our customers. As clinical diagnostics become increasingly complex, our advanced software will ensure you stay at the forefront of technology.

ic_discover_pink

Transparency

Aiforia makes a commitment to keeping our AI algorithms transparent and understandable. You remain in control, see how analyses are conducted, and participate in the training process. AI models serve as first-read support while the expert verifies the results. We offer our customers with fully quantifiable data and results that can easily be adjusted.

ic_wellbeing_pink

Ease of Use

The Aiforia software requires no data scientists or coding expertise. Our team of experts integrates the solutions into existing IT infrastructures. We acknowledge that every lab is different, so we optimize each model for each lab’s individual needs and monitor their performance to deliver continuous improvement. Aiforia’s software allows customers to confidently scale up their operations while paying only for what they need.

ic_secure_pink

Security

We take data privacy and security very seriously.  We hold several globally relevant quality and security certifications, so our customers can be sure their sample and patient data is safe.* Customers determine what information is stored in the cloud and can opt for a private version.
 

*Our image analysis solutions are developed and maintained securely per ISO 27001:2013 and SOC 2 Type II security standards, and  ISO 13485:2016 quality standards. 

News

See what's new

Aiforia signs a licensing agreement with the Mayo Clinic for an AI model that improves prediction of colorectal cancer recurrence

Aiforia signs a licensing agreement with the Mayo Clinic for an AI model that improves prediction of colorectal cancer recurrence

Aiforia has entered into an exclusive licensing agreement with the Mayo Clinic in the United States to globally commercialize an AI model that improves prediction of colorectal cancer recurrence.

January 2, 2024
Aiforia signs a deal with an Italian hospital in Catania

Aiforia signs a deal with an Italian hospital in Catania

The Provincial Health Authority of Catania in Italy has selected Aiforia Technologies Plc as a partner for AI-assisted diagnostics in the anatomic pathology laboratory of Gravina Hospital.

December 27, 2023
Looking back on 2023: A year of important milestones

Looking back on 2023: A year of important milestones

As 2023 concludes, CEO Jukka Tapaninen shares reflections on the key moments and achievements of Aiforia throughout the year.

December 21, 2023
Aiforia initiates path to secure its first regulatory approval in the United States – application to the FDA anticipated in 2024

Aiforia initiates path to secure its first regulatory approval in the United States – application to the FDA anticipated in 2024

Aiforia initiates path to secure its first regulatory approval in the United States – application to the FDA anticipated in 2024

October 20, 2023
Aiforia complies with applicable HIPAA regulations, enabling it to provide solutions to a broader range of customers in the US

Aiforia complies with applicable HIPAA regulations, enabling it to provide solutions to a broader range of customers in the US

Aiforia complies with applicable HIPAA regulations, enabling it to provide solutions to a broader range of customers in the US

September 18, 2023
Aiforia and Orion collaborate to develop AI solutions for image analytics in drug research

Aiforia and Orion collaborate to develop AI solutions for image analytics in drug research

Aiforia and Finnish pharmaceutical company Orion have agreed to collaborate on developing AI-based image analysis solutions for preclinical research and product development.

July 5, 2023

Who do we work with?

microsoft
logo_Charles_River_CRL
logo_nvidia-inception-premier-member-badge-rgb-for-screen
logo_sectra
logo_DPA
logo_XZELL
logo_NSA
logo_Epredia
WE Partner Pledge Badge_transparent
logo_compumed
logo_pathlake
Book a free demonstration

Seeing is believing

Book a demo